Association of pre-chemotherapy peripheral blood pro-inflammatory and coagulation factors with reduced relative dose intensity in women with breast cancer-Reference-Cited by-同舟云学术

Association of pre-chemotherapy peripheral blood pro-inflammatory and coagulation factors with reduced relative dose intensity in women with breast cancer

Published:2017-08-29 Issue:1 Volume:19 Page:
ISSN:1465-542X
Container-title:Breast Cancer Research
language:en
Short-container-title:Breast Cancer Res

Author:

Yuan Yuan,Vora Nilesh,Sun Can-Lan,Li Daneng,Soto-Perez-de-Celis Enrique,Mortimer Joanne,Luu The-hang,Somlo George,Waisman James,Smith David,Chao Joseph,Katheria Vani,Synold Timothy,Tran Vivi,Mi Shu,Levi Abrahm,Arsenyan Anait,Choi Jennifer,Zavala Laura,Yost Susan,Hurria Arti

Funder

National Institute on Aging

National Institutes of Health

National Cancer Institute

Conquer Cancer Foundation

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/s13058-017-0895-5.pdf

Reference44 articles.

1. Shayne M, Crawford J, Dale DC, Culakova E, Lyman GH, Group ANCS. Predictors of reduced dose intensity in patients with early-stage breast cancer receiving adjuvant chemotherapy. Breast Cancer Res Treat. 2006;100:255–62.

2. Bonadonna G, Valagussa P, Moliterni A, Zambetti M, Brambilla C. Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up. N Engl J Med. 1995;332:901–6.